AI in clinical trial adherence and retention: is it a Pandora’s box?
Clinical Trials Arena demystifies how AI can potentially help participants stick to the study all the way to the end, while also pointing to clinical trial…
By
Urtė Fultinavičiūtė
Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy.
Latest articles
All Articles
Tested solutions to solve new challenges: breaking silos key in future proofing clinical trial supply chains
Data, proactively seeking innovation, and clear governance are key tools in future-proofing supply chains in clinical trials.
By
Pipeline Moves: Sorrento terminates Phase Ib CAR-T pancreatic cancer trial, shot at further study drops
Kinnov Therapeutics in alcohol addiction and Genmab in fallopian tube cancer are also reviewed by Clinical Trials Arena.
By
Renovia, ObvioHealth conclude fully virtual medical device trial in urogynaecology
The medical device study investigated Renovia’s Leva, designed to help users perform Kegels more effectively.
By
Pipeline Moves: Harpoon secures Fast-Track for multiple myeloma asset, shot at further study rise
Clinical Trials Arena also reviews other Phase I assets by Lumen Bioscience, Pfizer, and Lung Therapeutics.
By
Covid-19, flu combo vaccines an advance but with rollout quandaries
Experts were less keen on variant-specific or multivariant Covid-19 vaccines owing to lack of practical value despite scientific rationale.
By
Pipeline Moves: Pfizer’s infectious disease vaccine misses primary endpoint, approval shot drops
The Clinical Trials Arena team also looks into Celyad in colorectal cancer after its Phase Ib termination.
By
Pipeline Moves: Arog Pharma terminates early-phase cancer trial, progress prospects tumble
Mesoblast in ulcerative colitis and Sage in major depressive disorder are also reviewed by Clinical Trials Arena.
By
Enrolment challenges persist in eating disorder clinical trials despite diagnosis increase
Social media, earlier help-seeking, and worsening of symptoms due to lockdowns contribute to increase in eating disorder diagnosis.
By